Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Our understanding of the fundamental biology and identification of efficacious therapeutic targets in aortic valve stenosis has lagged far behind the fields of atherosclerosis and heart failure. In this review, we highlight the most clinically relevant problems facing men and women with fibrocalcific aortic valve stenosis, discuss the fundamental biology underlying valve calcification and fibrosis, and identify key molecular points of intersection with sex hormone signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642
Otto, C. M., Burwash, I. G., Legget, M. E., Munt, B. I., Fujioka, M., Healy, N. L., Kraft, C. D., Miyake-Hull, C. Y., & Schwaegler, R. G. (1997) · Circulation · doi:10.1161/01.cir.95.9.2262 · Cited by 1,146 · cited 1×
“Patients with FCAVS incur highly variable rates of hemodynamic progression, with rates of progression ranging from 3 to 19 mmHg per year (72, 127, 141).”
BackgroundFreeman, R. V., & Otto, C. M. (2005) · Circulation · doi:10.1161/circulationaha.104.486738 · Cited by 1,006
Hachicha, Z., Dumesnil, J. G., Bogaty, P., & Pibarot, P. (2007) · Circulation · doi:10.1161/circulationaha.106.668681 · Cited by 959 · cited 1×
“However, a growing subset of patients present with a small valve area but a low transvalvular pressure gradient (71).”
BackgroundActivation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738
Self-citationImpact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Weidemann, F., Herrmann, S., Störk, S., Niemann, M., Frantz, S., Lange, V., Beer, M., Gattenlöhner, S., Voelker, W., Ertl, G., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.847772 · Cited by 706
Arnold, A. P., & Chen, X. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.001 · Cited by 587
The Complex Nature of Discordant Severe Calcified Aortic Valve Disease Grading
Clavel, M.-A., Messika-Zeitoun, D., Pibarot, P., Aggarwal, S. R., Malouf, J., Araoz, P. A., Michelena, H. I., Cueff, C., Larose, E., Capoulade, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1621 · Cited by 569
Self-citationCueff, C., Serfaty, J.-M., Cimadevilla, C., Laissy, J.-P., Himbert, D., Tubach, F., Duval, X., Iung, B., Enriquez-Sarano, M., Vahanian, A., et al. (2011) · Heart · doi:10.1136/hrt.2010.198853 · Cited by 385
Self-citationSingh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., et al. (2015) · Nature · doi:10.1038/nature14332 · Cited by 353
New Insights Into the Progression of Aortic Stenosis: Implications for Secondary Prevention
Palta, S., Pai, A. M., Gill, K. S., & Pai, R. G. (2000) · Circulation · doi:10.1161/01.cir.101.21.2497 · Cited by 319
Aggarwal, S. R., Clavel, M.-A., Messika-Zeitoun, D., Cueff, C., Malouf, J., Araoz, P. A., Mankad, R., Michelena, H., Vahanian, A., & Enriquez-Sarano, M. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.980052 · Cited by 280
Self-citationDweck, M. R., Jenkins, W. S. A., Vesey, A. T., Pringle, M. A. H., Chin, C. W. L., Malley, T. S., Cowie, W. J. A., Tsampasian, V., Richardson, H., Fletcher, A., et al. (2014) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.001508 · Cited by 260
Wnt signaling in heart valve development and osteogenic gene induction
Alfieri, C. M., Cheek, J., Chakraborty, S., & Yutzey, K. E. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.11.030 · Cited by 138 · cited 3×
“Frizzled subunits) (5, 6, 26, 31), and nuclear local-”
Basic Mechanisms of Calcific Aortic Valve Disease
Mathieu, P., & Boulanger, M.-C. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.029 · Cited by 107
Haemodynamic and anatomic progression of aortic stenosis
Nguyen, V., Cimadevilla, C., Estellat, C., Codogno, I., Huart, V., Benessiano, J., Duval, X., Pibarot, P., Clavel, M. A., Enriquez-Sarano, M., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307154 · Cited by 81 · cited 3×
“In patients who have reached the point of established aortic stenosis and continue to be monitored medically, total AVC progresses at a rate close to 200 AU/yr (132), with a significant correlation between calcium and hemodynamic progression.”
BackgroundInfluentialSelf-citationRoos, C. M., Hagler, M., Zhang, B., Oehler, E. A., Arghami, A., & Miller, J. D. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00735.2012 · Cited by 54
Self-citation
Cited by
Driscoll, K., Cruz, A. D., & Butcher, J. T. (2021) · Circulation Research · doi:10.1161/circresaha.121.318011 · Cited by 102
Genes that escape X chromosome inactivation modulate sex differences in valve myofibroblasts
Aguado, B. A., Walker, C. J., Grim, J. C., Schroeder, M. E., Batan, D., Vogt, B. J., Rodriguez, A. G., Schwisow, J. A., Moulton, K. S., Weiss, R. M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.054108 · Cited by 87
Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis
Myasoedova, V. A., Massaiu, I., Moschetta, D., Chiesa, M., Songia, P., Valerio, V., Alfieri, V., Capoulade, R., Trabattoni, D., Andreini, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.747714 · Cited by 32
Metadata
- Authors
- Sritharen, Y., Enriquez-Sarano, M., Schaff, H. V., Casaclang-Verzosa, G., & Miller, J. D.
- Venue
- Physiology
- Publisher
- American Physiological Society
- Published
- 2017-05
- Volume
- 32
- Issue
- 3
- Pages
- 182-196
- ISSN
- 0886-1714 (ISSN-L)
- 1548-9213
- 1548-9221
- OpenAlex
- W2606854055
- Cited by
- 43
- References
- 23
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.